Table 1.
Clinical characteristics of studies included in the review
| No. of patient | Age (yr) (median) | Sex (M/F) | First therapy method | Second therapy method | Operation duration time (min) | Median hospital stay (d) | Symptom remission rate (n/N, %) | |
| Ali et al[24] | 19 | 33 (14-74) | 12/7 | 19 PD | LM | 104 (50-198) | 3.2 | 14/19 (77.8) |
| Wills et al[25] | 44 | 47 (12-87) | 20/24 | 44 PD | LM | NA | NA | 32/44 (72.7) |
| Rosati et al[26] | 15 | 36 (12-54) | 9/8 | 15 PD | LM + Dor | 114 (60-200) | 6 (3-14) | 14/15 (93) |
| Pechlivanides et al[27] | 29 | 47 (12-74) | 12/17 | 29 PD | LM + Dor | 82 (45-105) | 2.6 (1-8) | 26/29 (90) |
| Omura et al[28] | 18 | 42 (16-65) | 10/8 | 18 PD | LM + Dor | 150 (120-205) | 8 (4-18) | 16/18 (88.9) |
| Gockel et al[29] | 67 | 44 (14-87) | 40/27 | 67 PD | HM + Dor | 104 (50-198) | 3.2 | 52/67 (77) |
| Ponce et al[30] | 32 | 32 (18-67) | 14/18 | 32 PD | HM + Dor | 120 (90-210) | 6 (3-11) | 26/32 (81.3) |
| Beckingham et al[31] | 10 | 30 (18-46) | 4/6 | 10 PD | LM | 90 (58-180) | 3 (2-4) | 9/10 (90) |
| Patti et al[32] | 66 | 46 (20-72) | 36/30 | 66 PD-BoTx | LM + Dor | 156 | 3.5 | 54/66 (83) |
| Duffy et al[33] | 5 | 39 (15-67) | 3/2 | 5 LM | LM + Toupet | 96 (87-120) | 2 | 5/5 (100) |
| Iqbal et al[34] | 15 | 42 (20-65) | 8/7 | 15 LM | LM | NA | NA | 12/15 (80) |
| Grotenhuis et al[35] | 19 | NA | 6/13 | 19 LM | HM + Dor | 101 (90-128) | 4 | 17/19 (89.5) |
| Glatz et al[36] | 8 | 52 (18-62) | 3/5 | 8 HM | HM | 90 (78-124) | 3.5 | 6/8 (74) |
| Robinson et al[37] | 3 | 34 (28-45) | 1/2 | 3 TM | LM | NA | NA | 100 |
| Rakita et al[38] | 12 | 40 (20-52) | 5/7 | 10 TM | LM | 98 (90-112) | 4.5 | 73 |
| Gorecki et al[39] | 8 | 38 (24-60) | 4/4 | 8 LM | 8 LM | NA | NA | 87.50 |
LM: Laparoscopic HM; NA: No analysis; HM + Dor: HM and Dor fundoplication; LM + Dor: Laparoscopic HM and Dor fundoplication; LM + Toupet: Laparoscopic HM and Toupet fundoplication.